Annual CFF
$30.00 K
-$75.23 M-99.96%
December 31, 2023
Summary
- As of February 6, 2025, LRMR annual cash flow from financing activities is $30.00 thousand, with the most recent change of -$75.23 million (-99.96%) on December 31, 2023.
- During the last 3 years, LRMR annual CFF has fallen by -$93.56 million (-99.97%).
- LRMR annual CFF is now -99.97% below its all-time high of $93.59 million, reached on December 31, 2020.
Performance
LRMR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$30.00 K
+$364.00 K+108.98%
September 30, 2024
Summary
- As of February 6, 2025, LRMR quarterly cash flow from financing activities is $30.00 thousand, with the most recent change of +$364.00 thousand (+108.98%) on September 30, 2024.
- Over the past year, LRMR quarterly CFF has increased by +$364.00 thousand (+108.98%).
- LRMR quarterly CFF is now -99.98% below its all-time high of $162.15 million, reached on March 31, 2024.
Performance
LRMR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$161.85 M
$0.000.00%
September 30, 2024
Summary
- As of February 6, 2025, LRMR TTM cash flow from financing activities is $161.85 million, unchanged on September 30, 2024.
- Over the past year, LRMR TTM CFF has stayed the same.
- LRMR TTM CFF is now -0.21% below its all-time high of $162.18 million, reached on March 31, 2024.
Performance
LRMR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LRMR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | +109.0% | 0.0% |
| 3 y3 years | -100.0% | +109.0% | 0.0% |
| 5 y5 years | -99.8% | +109.0% | 0.0% |
LRMR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | +109.0% | -0.2% | >+9999.0% |
| 5 y | 5-year | -100.0% | at low | -100.0% | +109.0% | -0.2% | >+9999.0% |
| alltime | all time | -100.0% | at low | -100.0% | +109.0% | -0.2% | >+9999.0% |
Larimar Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $30.00 K(-109.0%) | $161.85 M(0.0%) |
| Jun 2024 | - | -$334.00 K(-100.2%) | $161.85 M(-0.2%) |
| Mar 2024 | - | $162.15 M(>+9900.0%) | $162.18 M(>+9900.0%) |
| Dec 2023 | $30.00 K(-100.0%) | $0.00(-100.0%) | $30.00 K(-110.5%) |
| Sep 2023 | - | $30.00 K(>+9900.0%) | -$286.00 K(-100.4%) |
| Jun 2023 | - | $0.00(0.0%) | $75.26 M(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $75.26 M(0.0%) |
| Dec 2022 | $75.26 M | -$316.00 K(-100.4%) | $75.26 M(-0.4%) |
| Sep 2022 | - | $75.57 M(>+9900.0%) | $75.57 M(+280.1%) |
| Jun 2022 | - | $0.00(0.0%) | $19.89 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(0.0%) | $19.89 M(0.0%) |
| Dec 2021 | $19.89 M(-78.8%) | $0.00(-100.0%) | $19.89 M(-1.2%) |
| Sep 2021 | - | $19.89 M(>+9900.0%) | $20.13 M(>+9900.0%) |
| Jun 2021 | - | $0.00(0.0%) | $107.00 K(-99.9%) |
| Mar 2021 | - | $0.00(-100.0%) | $84.01 M(-10.2%) |
| Dec 2020 | $93.59 M(+382.5%) | $242.00 K(-279.3%) | $93.59 M(+0.3%) |
| Sep 2020 | - | -$135.00 K(-100.2%) | $93.34 M(-0.1%) |
| Jun 2020 | - | $83.90 M(+776.1%) | $93.48 M(+876.1%) |
| Mar 2020 | - | $9.58 M | $9.58 M |
| Dec 2019 | $19.39 M | - | - |
FAQ
- What is Larimar Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Larimar Therapeutics?
- What is Larimar Therapeutics annual CFF year-on-year change?
- What is Larimar Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly CFF year-on-year change?
- What is Larimar Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Larimar Therapeutics?
- What is Larimar Therapeutics TTM CFF year-on-year change?
What is Larimar Therapeutics annual cash flow from financing activities?
The current annual CFF of LRMR is $30.00 K
What is the all time high annual CFF for Larimar Therapeutics?
Larimar Therapeutics all-time high annual cash flow from financing activities is $93.59 M
What is Larimar Therapeutics annual CFF year-on-year change?
Over the past year, LRMR annual cash flow from financing activities has changed by -$75.23 M (-99.96%)
What is Larimar Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of LRMR is $30.00 K
What is the all time high quarterly CFF for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly cash flow from financing activities is $162.15 M
What is Larimar Therapeutics quarterly CFF year-on-year change?
Over the past year, LRMR quarterly cash flow from financing activities has changed by +$364.00 K (+108.98%)
What is Larimar Therapeutics TTM cash flow from financing activities?
The current TTM CFF of LRMR is $161.85 M
What is the all time high TTM CFF for Larimar Therapeutics?
Larimar Therapeutics all-time high TTM cash flow from financing activities is $162.18 M
What is Larimar Therapeutics TTM CFF year-on-year change?
Over the past year, LRMR TTM cash flow from financing activities has changed by $0.00 (0.00%)